ThirdLaw Molecular, Inc., 2025-10-08
An SEC Form D private-offering notice from Blue Bell, PA, a $5,500,000 filer-stated offering target in Biotech. Filed 2025-10-08. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotechnology company (recently rebranded Ladder Bio) developing Spiroligomer therapeutics: ladder shaped peptide like molecules designed to engage difficult biological targets, spun out of Temple University research.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Lumora Clinic Services LLC, 2025-10-14, $3.5M, Philadelphia, PA
- BioRestorative Therapies, Inc., 2025-10-09, $1.4M, Melville, NY
- BluPanda, LLC, 2025-10-09, $2.5M, Apollo, PA
- Rinascera Therapeutics, Inc., 2025-10-08, $2.5M, Boston, MA
- BlastPoint, Inc., 2025-10-09, $15.6M, Pittsburgh, PA
- Mati Therapeutics Inc., 2025-10-08, $10.5M, Austin, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.